Combinational treatments of RNA interference and extracellular vesicles in the spinocerebellar ataxia

Spinocerebellar ataxia (SCA) is an autosomal dominant neurodegenerative disease (ND) with a high mortality rate. Symptomatic treatment is the only clinically adopted treatment. However, it has poor effect and serious complications. Traditional diagnostic methods [such as magnetic resonance imaging (...

Full description

Bibliographic Details
Main Authors: Yingying Ding, Yong Zhang, Xuehong Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Molecular Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnmol.2022.1043947/full
_version_ 1811342027485347840
author Yingying Ding
Yingying Ding
Yong Zhang
Xuehong Liu
author_facet Yingying Ding
Yingying Ding
Yong Zhang
Xuehong Liu
author_sort Yingying Ding
collection DOAJ
description Spinocerebellar ataxia (SCA) is an autosomal dominant neurodegenerative disease (ND) with a high mortality rate. Symptomatic treatment is the only clinically adopted treatment. However, it has poor effect and serious complications. Traditional diagnostic methods [such as magnetic resonance imaging (MRI)] have drawbacks. Presently, the superiority of RNA interference (RNAi) and extracellular vesicles (EVs) in improving SCA has attracted extensive attention. Both can serve as the potential biomarkers for the diagnosing and monitoring disease progression. Herein, we analyzed the basis and prospect of therapies for SCA. Meanwhile, we elaborated the development and application of miRNAs, siRNAs, shRNAs, and EVs in the diagnosis and treatment of SCA. We propose the combination of RNAi and EVs to avoid the adverse factors of their respective treatment and maximize the benefits of treatment through the technology of EVs loaded with RNA. Obviously, the combinational therapy of RNAi and EVs may more accurately diagnose and cure SCA.
first_indexed 2024-04-13T19:04:08Z
format Article
id doaj.art-e3856c54c8114629bb03f4acf0af3efb
institution Directory Open Access Journal
issn 1662-5099
language English
last_indexed 2024-04-13T19:04:08Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Neuroscience
spelling doaj.art-e3856c54c8114629bb03f4acf0af3efb2022-12-22T02:34:02ZengFrontiers Media S.A.Frontiers in Molecular Neuroscience1662-50992022-10-011510.3389/fnmol.2022.10439471043947Combinational treatments of RNA interference and extracellular vesicles in the spinocerebellar ataxiaYingying Ding0Yingying Ding1Yong Zhang2Xuehong Liu3Department of Histology and Embryology, Medical College, Shaoxing University, Shaoxing, Zhejiang, ChinaDepartment of Clinical Medicine, Affiliated Hospital of Hangzhou Normal University, Hangzhou, ChinaDepartment of Histology and Embryology, Medical College, Shaoxing University, Shaoxing, Zhejiang, ChinaDepartment of Histology and Embryology, Medical College, Shaoxing University, Shaoxing, Zhejiang, ChinaSpinocerebellar ataxia (SCA) is an autosomal dominant neurodegenerative disease (ND) with a high mortality rate. Symptomatic treatment is the only clinically adopted treatment. However, it has poor effect and serious complications. Traditional diagnostic methods [such as magnetic resonance imaging (MRI)] have drawbacks. Presently, the superiority of RNA interference (RNAi) and extracellular vesicles (EVs) in improving SCA has attracted extensive attention. Both can serve as the potential biomarkers for the diagnosing and monitoring disease progression. Herein, we analyzed the basis and prospect of therapies for SCA. Meanwhile, we elaborated the development and application of miRNAs, siRNAs, shRNAs, and EVs in the diagnosis and treatment of SCA. We propose the combination of RNAi and EVs to avoid the adverse factors of their respective treatment and maximize the benefits of treatment through the technology of EVs loaded with RNA. Obviously, the combinational therapy of RNAi and EVs may more accurately diagnose and cure SCA.https://www.frontiersin.org/articles/10.3389/fnmol.2022.1043947/fullextracellular vesicleRNA interferencemiRNAsiRNAshRNAspinocerebellar ataxia
spellingShingle Yingying Ding
Yingying Ding
Yong Zhang
Xuehong Liu
Combinational treatments of RNA interference and extracellular vesicles in the spinocerebellar ataxia
Frontiers in Molecular Neuroscience
extracellular vesicle
RNA interference
miRNA
siRNA
shRNA
spinocerebellar ataxia
title Combinational treatments of RNA interference and extracellular vesicles in the spinocerebellar ataxia
title_full Combinational treatments of RNA interference and extracellular vesicles in the spinocerebellar ataxia
title_fullStr Combinational treatments of RNA interference and extracellular vesicles in the spinocerebellar ataxia
title_full_unstemmed Combinational treatments of RNA interference and extracellular vesicles in the spinocerebellar ataxia
title_short Combinational treatments of RNA interference and extracellular vesicles in the spinocerebellar ataxia
title_sort combinational treatments of rna interference and extracellular vesicles in the spinocerebellar ataxia
topic extracellular vesicle
RNA interference
miRNA
siRNA
shRNA
spinocerebellar ataxia
url https://www.frontiersin.org/articles/10.3389/fnmol.2022.1043947/full
work_keys_str_mv AT yingyingding combinationaltreatmentsofrnainterferenceandextracellularvesiclesinthespinocerebellarataxia
AT yingyingding combinationaltreatmentsofrnainterferenceandextracellularvesiclesinthespinocerebellarataxia
AT yongzhang combinationaltreatmentsofrnainterferenceandextracellularvesiclesinthespinocerebellarataxia
AT xuehongliu combinationaltreatmentsofrnainterferenceandextracellularvesiclesinthespinocerebellarataxia